Literature DB >> 1461345

Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.

B Stein-Behrens1, K Adams, M Yeh, R Sapolsky.   

Abstract

Considerable excitement has been generated as of late over reports that fragments of the amyloid precursor protein can be neurotoxic both in vivo and in vitro. In this brief report we study the neurotoxicity of the fragment corresponding to amino acids 25-35 of the beta-amyloid protein in the hippocampus in vivo. Under the conditions studied, we do not observe any evidence of consistent, dose-related damage above that seen with vehicle alone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461345     DOI: 10.1016/0197-4580(92)90058-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid.

Authors:  K N Prasad; F G La Rosa; J E Prasad
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-03       Impact factor: 2.416

3.  Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice.

Authors:  J G Sheng; R E Mrak; K R Bales; B Cordell; S M Paul; R A Jones; S Woodward; X Q Zhou; J M McGinness; W S Griffin
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

Review 4.  Interleukin-1 and the immunogenetics of Alzheimer disease.

Authors:  R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  2000-06       Impact factor: 3.685

5.  High-level expression and in vitro mutagenesis of a fibrillogenic 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein.

Authors:  J E Gardella; G A Gorgone; L Candela; J Ghiso; E M Castaño; B Frangione; P D Gorevic
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

6.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Authors:  M A Pappolla; Y J Chyan; R A Omar; K Hsiao; G Perry; M A Smith; P Bozner
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

Review 7.  beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.

Authors:  N Arispe; H B Pollard; E Rojas
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

8.  A comparative study of beta-amyloid peptides Abeta1-42 and Abeta25-35 toxicity in organotypic hippocampal slice cultures.

Authors:  Rudimar Luiz Frozza; Ana Paula Horn; Juliana Bender Hoppe; Fabrício Simão; Daniéli Gerhardt; Ricardo Argenta Comiran; Christianne Gazzana Salbego
Journal:  Neurochem Res       Date:  2008-08-07       Impact factor: 3.996

9.  Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide.

Authors:  C L Shen; M C Fitzgerald; R M Murphy
Journal:  Biophys J       Date:  1994-09       Impact factor: 4.033

10.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

Authors:  A J Bruce; B Malfroy; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.